期刊文献+

芪丹通脉片对缺氧大鼠血管内皮生长因子的双向调节作用 被引量:1

Regulation Effect of Qidantongmai Tablet on VEGF Expression in Rats with Hypoxic
下载PDF
导出
摘要 目的探讨活血化瘀复方中药芪丹通脉片(QDTMT)对缺氧模型大鼠血清血管内皮生长因子(VEGF)浓度的影响及其内皮保护作用的相关分子机制。方法将大鼠随机分为正常对照组、低氧+QDTMT组(QDTMT组)、低氧+生理盐水组(生理盐水对照组),采用低压低氧法建立大鼠缺氧模型,并对肝脏组织进行病理形态学分析;分别于缺氧1周后、缺氧2周后用ELISA试剂盒检测各组大鼠血清中VEGF含量。结果造模后,QDTMT组病理形态学损伤较轻。缺氧1周后,QDTMT组大鼠血清中VEGF含量明显高于正常对照组和生理盐水对照组;缺氧2周后,QDTMT组大鼠VEGF含量仍高于正常对照组,但明显低于生理盐水对照组。结论缺氧后QDTMT对VEGF分泌的双向调节作用,可能为其内皮保护机制之一。 Objective: To find the protective molecular mechanisms of TraditionalChinese Medicine, and to study the effects of Qidantongmai Tablet(QDTMT) on the expression level of VEGF and KDR in rats with hypoxie model. Methods Rats were randomly divided into 3 groups normal, treatment and control. Before analysis the liver pathological changes, the rats were exposed to low pressure and low oxygen conditions in hypobaric and hypoxic chamber for the establishment of animal model. After 1 week and 2 weeks of bypoxia, concentrations of VEGF in rat serum were detected. Results The liver pathological changes decreased in treatment group. After 1 week of hypoxia, that the concentration of VEGF in serum of treatment group was higher than that of control group and normal group, After 2 weeks of hypoxia, the VEGF level of control group was higher than that of treatment group. Conclusion Two, ways regulation effect on VEGF level may be one of the mechanism for QDTMT to protect the endothelial tissue in hypoxia condition.
出处 《中国中医急症》 2008年第11期1563-1564,共2页 Journal of Emergency in Traditional Chinese Medicine
基金 "十一五"军队中医药重大临床攻关专项课题(No.2006191001) 陕西省中医药管理局科研课题(No.2007035)
关键词 芪丹通脉片 缺氧 血管内皮生长因子 大鼠 Qidantongmai Tablet Hypoxia VEGF Rat
  • 相关文献

参考文献9

二级参考文献39

共引文献71

同被引文献14

  • 1孟华,朱妙章,黄晨.中药在治疗性血管生成中的应用进展及前景[J].心脏杂志,2005,17(4):395-397. 被引量:3
  • 2孙新,苏慧,臧益民,王跃民,毕辉,郭海涛,槐勇,裴建明.U50488H对低氧性肺动脉高压大鼠体内一氧化氮、内皮素及血管紧张素Ⅱ水平的影响[J].心脏杂志,2007,19(3):249-251. 被引量:18
  • 3Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family [J]. Cardiovasc Res, 2001, 49(3) :568 -581.
  • 4Herve MA, Meduri G, Petit FG, et al. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus[J].. J Endocrinol, 2006, 188(1) :91 -99.
  • 5Yla-Herttuala S, Rissanen TT, Vajanto I, et al. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine [ J ]. J Am Coll Cardiol, 2007,49 ( 10 ) : 1015 - 1026.
  • 6Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors[J]. Nat Med, 2003, 9(6) :669 -676.
  • 7Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis[ J]. J Biochem Mol Biol, 2006, 39(5) :469 -478.
  • 8Gille H, Kowalski J, Li B, et al. Analysis of biological effects and signaling properties of Fh-1 ( VEGFR-1 ) and KDR ( VEGFR-2 ) [ J ]. J Biol Chem, 2001, 276 ( 5 ) :3222 - 3230.
  • 9Brogi E, Schatteman G, Wu T, et al. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression [J]. J Clin Invest, 1996, 97(2) :469 -476.
  • 10Kumazaki K, Nakayama M, Suehara N, et al. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions[J]. Hum Pathol, 2002, 33( 11 ) :1069 - 1077.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部